Moderna (MRNA US): To Cash in on Omicron Fear
Moderna is set to fly high on the continuous increasing demand for its Covid vaccine and rich pipeline beyond Covid. Emerging Omicron variant is...
405 Views
SD Biosensor (137310 KS): COVID Test Revenue Tapering Off; Global Expansion to Drive Future Growth
SD Biosensor is expected to take massive hit in revenue in 2023 due to declining COVID tests. However, new product launches and global expansion...
459 Views
New Covid Variant Raises Fear: Stocks to Own to Buck the Trend
Amidst the rising fear for the new Covid variant, investors can focus on molecular diagnostic stocks, as testing demand will be increasing again.
527 Views
Smartkarma Originals
Asian Healthcare - Coming of Age
This Smartkarma Originals Insight highlights 20 leading unlisted healthcare companies in Asia, mainly in digital healthcare and biopharma, that are...
864 Views
Qiagen/Thermo Fisher: Qiagen Gets a Bump – Is It Enough to Satisfy Shareholders?
QIAGEN NV (QIA GY) shares have gone from strength to strength with the stock trading above terms and then receiving a bump bid late last week....
415 Views